Board Meeting12 Aug 2026, 08:01 pm
Bliss GVS Pharma Board Approves Q1 FY27 Unaudited Financial Results
AI Summary
Bliss GVS Pharma Ltd announced that its Board of Directors met on August 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved a draft postal ballot notice for the appointment of Mr. Santosh Parab as a Non-Executive Non-Independent Director. The meeting was conducted via Video Conferencing/Other Audio Visual Means.
Key Highlights
- Board meeting held on August 12, 2026.
- Approved unaudited standalone and consolidated financial results for Q1 FY27.
- Approved appointment of Mr. Santosh Parab as Director.
- Meeting conducted via Video Conferencing/OAVM.
Price Impact
More from BLISSGVS